HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rescue of enzymatic function for disease-associated RPE65 proteins containing various missense mutations in non-active sites.

Abstract
Over 70 different missense mutations, including a dominant mutation, in RPE65 retinoid isomerase are associated with distinct forms of retinal degeneration; however, the disease mechanisms for most of these mutations have not been studied. Although some mutations have been shown to abolish enzyme activity, the molecular mechanisms leading to the loss of enzymatic function and retinal degeneration remain poorly understood. Here we show that the 26 S proteasome non-ATPase regulatory subunit 13 (PSMD13), a newly identified negative regulator of RPE65, plays a critical role in regulating pathogenicity of three mutations (L22P, T101I, and L408P) by mediating rapid degradation of mutated RPE65s via a ubiquitination- and proteasome-dependent non-lysosomal pathway. These mutant RPE65s were misfolded and formed aggregates or high molecular complexes via disulfide bonds. Interaction of PSMD13 with mutant RPE65s promoted degradation of misfolded but not properly folded mutant RPE65s. Many mutations, including L22P, T101I, and L408P, were mapped on non-active sites. Although their activities were very low, these mutant RPE65s were catalytically active and could be significantly rescued at low temperature, whereas mutant RPE65s with a distinct active site mutation could not be rescued under the same conditions. Sodium 4-phenylbutyrate and glycerol displayed a significant synergistic effect on the low temperature rescue of the mutant RPE65s by promoting proper folding, reducing aggregation, and increasing membrane association. Our results suggest that a low temperature eye mask and sodium 4-phenylbutyrate, a United States Food and Drug Administration-approved oral medicine, may provide a promising "protein repair therapy" that can enhance the efficacy of gene therapy by reducing the cytotoxic effect of misfolded mutant RPE65s.
AuthorsSonghua Li, Tadahide Izumi, Jane Hu, Heather H Jin, Ahmed-Abdul A Siddiqui, Samuel G Jacobson, Dean Bok, Minghao Jin
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 289 Issue 27 Pg. 18943-56 (Jul 04 2014) ISSN: 1083-351X [Electronic] United States
PMID24849605 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.
Chemical References
  • Mutant Proteins
  • Phenylbutyrates
  • 4-phenylbutyric acid
  • retinoid isomerohydrolase
  • Proteasome Endopeptidase Complex
  • ATP dependent 26S protease
  • 26S proteasome non-ATPase regulatory subunit 13
  • cis-trans-Isomerases
  • Glycerol
Topics
  • Animals
  • Catalytic Domain
  • Cell Membrane (drug effects, metabolism)
  • Disease (genetics)
  • Gene Expression Regulation, Enzymologic (drug effects)
  • Glycerol (pharmacology)
  • HEK293 Cells
  • Humans
  • Mice
  • Models, Molecular
  • Mutant Proteins (chemistry, genetics, metabolism)
  • Mutation, Missense
  • Phenylbutyrates (pharmacology)
  • Proteasome Endopeptidase Complex (metabolism)
  • Protein Folding (drug effects)
  • Proteolysis (drug effects)
  • Retinal Pigment Epithelium (cytology)
  • Temperature
  • Ubiquitination (drug effects)
  • cis-trans-Isomerases (chemistry, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: